Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
In vivo/ex vivo T-cell depleti...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
In vivo/ex vivo T-cell depletion with anti-CD52 monoclonal antibodies: long-term results in patients with acute leukaemia in CR1
Bibliographic Details
Main Authors:
Bunjes, D
,
Wiesneth, M
,
Hertenstein, B
,
Stefanic, M
,
Duncker, C
,
Novotny, J
,
Heit, W
,
Arnold, R
,
Hale, G
,
Waldmann, H
,
Heimpel, H
Format:
Conference item
Published:
2004
Holdings
Description
Similar Items
Staff View
Similar Items
In vitro and in vivo depletion of T cells.
by: Arnold, R, et al.
Published: (1993)
Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
by: Heit, W, et al.
Published: (1986)
Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: comparison of ex vivo and in vivo T-cell depletion.
by: Cullis, J, et al.
Published: (1993)
Peripheral blood dendritic cells express CD52 and are depleted in-vivo by treatment with CAMPATH-1H.
by: Buggins, A, et al.
Published: (2001)
T-cell depletion of bone marrow grafts with Campath 1 ex vivo prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation
by: Novitzky, N, et al.
Published: (1997)